The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL
Open accessAbstract
HDL lowers the risk for atherosclerotic cardiovascular disease by promoting cholesterol efflux from macrophage foam cells. However, other antiatherosclerotic properties of HDL are poorly understood. To test the hypothesis that the lipoprotein carries proteins that might have novel cardioprotective activities, we used shotgun proteomics to investigate the composition of HDL isolated from healthy subjects and subjects with coronary artery disease (CAD). Unexpectedly, our analytical strategy identified multiple complement-regulatory proteins and a diverse array of distinct serpins with serine-type endopeptidase inhibitor activity. Many acute-phase response proteins were also detected, supporting the proposal that HDL is of central importance in inflammation. Mass spectrometry and biochemical analyses demonstrated that HDL3 from subjects with CAD was selectively enriched in apoE, raising the possibility that HDL carries a unique cargo of proteins in humans with clinically significant cardiovascular disease. Collectively, our observations suggest that HDL plays previously unsuspected roles in regulating the complement system and protecting tissue from proteolysis and that the protein cargo of HDL contributes to its antiinflammatory and antiatherogenic properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unlike HDL from healthy subjects, HDL from patients with CHD, kidney disease or diabetes mellitus have no protective vascular effects or may even cause paradoxical harmful effects [55, 56, 61, 70, 71, 75, 76].”
From HDL cholesterol: reappraisal of its clinical relevance (2017) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A statistical model for identifying proteins by tandem mass spectrometry.
Nesvizhskii, A., Keller, A., Kolker, E., & Aebersold, R. (2003) · Analytical Chemistry · doi:10.1021/ac0341261 · Cited by 4,902
A Model for Random Sampling and Estimation of Relative Protein Abundance in Shotgun Proteomics
Liu, H., Sadygov, R. G., & Yates, J. R. (2004) · Analytical Chemistry · doi:10.1021/ac0498563 · Cited by 2,533
Direct analysis of protein complexes using mass spectrometry
Link, A. J., Eng, J. K., Schieltz, D. M., Carmack, E., Mize, G. J., Morris, D. R., Garvik, B. M., & Yates, J. R. (1999) · Nature Biotechnology · doi:10.1038/10890 · Cited by 2,218
Identifying biological themes within lists of genes with EASE
Hosack, D. A., Dennis, G., Sherman, B. T., Lane, H. C., & Lempicki, R. A. (2003) · Genome biology · doi:10.1186/gb-2003-4-10-r70 · Cited by 1,961
Deaths: preliminary data for 2003.
Hoyert, D. L., Kung, H.-C., & Smith, B. L. (2005) · PubMed · Cited by 1,649
Effect of Statin Therapy on C-Reactive Protein Levels
Albert, M. A., Danielson, E., Rifai, N., Ridker, P. M., & for the PRINCE Investigators (2001) · JAMA · doi:10.1001/jama.286.1.64 · Cited by 1,644
Self-citationHigh-Density Lipoprotein — The Clinical Implications of Recent Studies
Desforges, J. F., Gordon, D. J., & Rifkind, B. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211907 · Cited by 1,547
Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities
Braunwald, E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371906 · Cited by 1,426
Antiinflammatory Properties of HDL
Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394
Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects
Graham, T. E., Yang, Q., Blüher, M., Hammarstedt, A., Ciaraldi, T. P., Henry, R. R., Wason, C. J., Oberbach, A., Jansson, P.-A., Smith, U., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054862 · Cited by 1,319
Research works printed but not linked: 4
- Hoyert, 2005, Natl. Vital Stat. Rep., 53, 1
- Gundry, 2007, J. Clin. Proteomics.
- Davies, 1990, Circulation., 82(Suppl.), II38
- Strunk, 1983, Immunology., 49, 169
Cited by
Sorted by citations
Items 901–944 of 944
(2009) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328329fcc2
Lipoprotein Metabolism and the Treatment of Lipid Disorders
Freeman, M. W. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00042-3
Kontush, A., & Chapman, M. J. (2011) · Wiley eBooks · doi:10.1002/9781118158678.ch1
The complement system and cardiovascular disease
Hertle, E. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20160401eh
Santana, M. F., Lira, A. L. D. A., Pinto, R. D. S., Minanni, C. A., Silva, A. R., Sawada, M. I., Nakandakare, E. R., Corrêa‐Giannella, M. L., Ronsein, G. E., Queiroz, M. S., et al. (2020) · doi:10.21203/rs.3.rs-30049/v1
Fazio, S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736866539.793567220
A practical approach to lipid management in the elderly
Viljoen, A. (2010) · The journal of nutrition health & aging · doi:10.1007/s12603-010-0301-9
The Role of level and function of High Density Lipoprotein (HDL) in Cardiovascular Diseases
آقاسی زاده, م., غیور مبرهن, م., کاظمی, ط., آوان, ا., & میری مقدم, ا. (2020) · مجله علمی دانشگاه علوم پزشکی بیرجند · doi:10.32592/jbirjandunimedsci.2020.27.2.100
Gerontología. Un enfoque interdisciplinario
Pérez, B. M. P., Morales‐González, J. A., Chapa, G. N., Cariño‐Cortés, R., & Martínez, R. E. M. (2023) · Universidad Autónoma del Estado de Hidalgo eBooks · doi:10.29057/books.125
Nicholls, S. J., & Nelson, A. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88286-6.00029-7
Identification of genetic drivers of plasma lipoproteins in the Diversity Outbred mouse populationPreprint
Price, T. R., Emfinger, C. H., Schueler, K. L., King, S. M., Nicholson, R. J., Beck, T., Yandell, B. S., Summers, S. A., Holland, W. L., Krauss, R. M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.26.554969
Huang, C., Zhang, J., Huang, J., Li, H., Wen, K., Bao, J., Wu, X., Sun, R., Abudukeremu, A., Wang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23606896
Huang, C., Zhang, J., Huang, J., Li, H., Wen, K., Bao, J., Wu, X., Sun, R., Abudukeremu, A., Wang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23606893
Mueller, P. A., Rosário, S., Hay, J., Bergstrom, P., Pacheco-Velázquez, S. C., Hegele, R. A., Pamir, N., & Purnell, J. Q. (2025) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.04.196
HDL: function, dysfunction and laboratory methods of determination
Novotný, D., Karásek, D., Vaverková, H., & Malina, P. (2013) · Klinická biochemie a metabolismus · doi:10.61568/kbm.2013.023
Deciphering Acute Coronary Syndromes Pathobiology Through Proteomics
Nieddu, G., Formato, M., & Lepedda, A. J. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12050188
Biological age on pause. The effect of nutraceuticals on endothelial dysfunction and aging processes
Орлова, С. В., Prokopenko, E. V., Никитина, Е. А., & Balashova, N. V. (2025) · Medical alphabet · doi:10.33667/2078-5631-2025-19-35-45
Structural model of the blood protein vitronectin bound to lipid and HDLPreprint
Shin, K., Brown, W., Tian, Y., Gopinath, T., Bobkov, A. A., Marinelli, F., & Marassi, F. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.01.685992
“Here, we present a structural model for lipid-bound and HDL-associated vitronectin (Vn), a multifunctional serum glycoprotein and component of the HDL proteome, found in the fraction of small, dense pre-β HDL particles associated with its acute phase response activities (5-8).”
Taylor, P. (2013) · Otago University Research Archive (University of Otago)
Chackathayil, J. (2013) · University of Birmingham Institutional Research Archive (University of Birmingham)
Additional file 1 of High-density lipoproteins during sepsis: from bench to bedside
Tanaka, S., Couret, D., Tran‐Dinh, A., Duranteau, J., Montravers, P., Schwendeman, A., & Meilhac, O. (2020) · Figshare · doi:10.6084/m9.figshare.12097314
Gordon, S., Amar, M. J., Jeiran, K., Stagliano, M., Staller, E., Playford, M. P., Mehta, N. N., Vaisar, T., & Remaley, A. T. (2020) · Figshare · doi:10.6084/m9.figshare.12845703
Self-citationKim, H. J., Jeong, S., Oh, Y. H., Park, S. J., Cho, Y., & Park, S. M. (2023) · Figshare · doi:10.6084/m9.figshare.22623655
Additional file 1 of ANGPTL3 is a novel HDL component that regulates HDL function
Yang, L., Wang, Y., Xu, Y., Li, K., Yin, R., Zhang, L., Wang, D., Wei, L., Lang, J., Cheng, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26691460
Vorozhko, I., Sidorova, Y., Biryulina, N., Zorin, S., Petrov, N. A., Korotkova, T., & Kochetkova, A. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48010110
Low HDL and high HDL syndromes
Yamashita, S., & Matsuzawa, Y. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00305-8
Surfactant Protein B and the Lung–HDL–Vascular Axis: Linking Pulmonary Injury to Cardiovascular Risk
Shao, B. (2026) · Current Atherosclerosis Reports · doi:10.1007/s11883-026-01391-6
“These findings indicate that incorporation of pro-SFTPB into HDL represents an early and sensitive marker of smoke-induced pulmonary injury and may precede overt vascular dysfunction. levels [ 26].”
The roles of endoplasmic reticulum stress and Bax inhibitor-1 in non-alcoholic fatty liver disease
Lebeaupin, C. (2018) · theses.fr (ABES) · doi:10.70675/de500ab2z3c59z484dz8f58z7c3173626c42
Clinical Assessment of Anti-Atherogenic Function of HighDensity Lipoprotein (HDL)
Ma, F. (2018) · theses.fr (ABES) · doi:10.70675/aec01babza8edz47a2zb4d4zc7c3be00b185
Omics of human plasma lipoproteins : role in cardiometabolic diseases
Zakiev, E. (2019) · theses.fr (ABES) · doi:10.70675/d80fee25za2f2z4790z9eb9ze82d5514a198
Jennett, J., Ruggiero-Ruff, R. E., Lam, K. M., Anesko, K., Chen, G., Midou, S., Ge, S., & Nair, M. G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.04.730169
“All genes with structural functions were significantly downregulated with infection in WT mice but not KO mice ( Col14a1, Fbln7, Fbln2, Serpinh1, Serpinf1, Col6a1 ) 5,6,12,30,68–73 .”
Semaev, S., Orlov, P. S., Щербакова, Л. В., Иванощук, Д. Е., Malyutina, S. K., Гафаров, В. В., Ragino, Y. I., & Шахтшнейдер, Е. В. (2026) · Ateroscleroz · doi:10.52727/2078-256x-2026-22-2-135-158
Cai, Y. N., Li, K., Ma, H., Wu, J., & Zheng, Y. (2026) · Antioxidants · doi:10.3390/antiox15070864
“Recent advancements in LC-MS/MS have facilitated the identification of more than 90 distinct proteins within the HDL proteome, extending beyond basic quantification of ApoA-I [64].”
InfluentialČerniauskas, L., Aleknavičiūtė-Valienė, G., Arbaciauskaite, S., Mytzka, N., Allelein, S., Bikulčienė, I., & Karčiauskaitė, D. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1831078
“Proteomic studies have also identified complement proteins, immunoglobulins, acute phase proteins, coagulation factors, and protease inhibitors associated with HDL particles (63, 72, 73).”
Free Fatty Acids Carried by Lipoproteins: Revisiting the Overlooked Cargo
Henderson, G. C., Buhman, K. K., & Tomoo, K. (2026) · Acta Physiologica · doi:10.1111/apha.70296
Ivanova, A., Schieltz, D. M., Gardner, M. S., Parks, B. A., Leszczynski, E. C., Sarzynski, M. A., Kraus, V. B., Kraus, W. E., Kuklenyik, Z., & Barr, J. R. (2026) · Clinical Chemistry · doi:10.1093/clinchem/hvag129
Black Elderberry Extract Reduces Cardiometabolic Risk by Lowering Inflammation in Mice
Farrell, N. J. (2015) · OpenCommons at University of Connecticut (University of Connecticut)
Metadata
- Authors
- Vaisar, T., Pennathur, S., Green, P. S., Gharib, S. A., Hoofnagle, A. N., Cheung, M. C., Byun, J., Vuletic, S., Kassim, S., Singh, P., Chea, H., Knopp, R. H., Brunzell, J., Geary, R., Chait, A., Zhao, X.-Q., Elkon, K., Marcovina, S., Ridker, P., Oram, J. F., & Heinecke, J. W.
- Affiliations
- University of Washington (US)
- Wake Forest University (US)
- Harvard University (US)
- Corresponding author
- Heinecke, Jay W.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-03-01
- Volume
- 117
- Issue
- 3
- Pages
- 746-756
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1804352
- OpenAlex
- W2083315579
- Cited by
- 942
- References
- 70
- Citations by year
- 2026: 16 · 2025: 20 · 2024: 19 · 2023: 25 · 2022: 36 · 2021: 28 · 2020: 35 · 2019: 36 · 2018: 45 · 2017: 31 · 2016: 51 · 2015: 69 · 2014: 58 · 2013: 81 · 2012: 79
- FWCI
- 79.98
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Washington (P30ES07033)
- National Institutes of Health (P30ES07033, DK017047)
- National Heart, Lung, and Blood Institute (HL086798, P01HL030086, HL-078527, K08HL074223, HL-57557, HL074223, R01HL086798, R01HL057557, R01HL078527)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK017047, DK 02456, P01DK002456, P30DK017047)
- National Institute of Environmental Health Sciences (P30 ES-07033, P30ES007033)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- HDL cholesterol, HDL proteome, complement regulation, serpins, protease inhibition, anti-inflammatory activity, coronary artery disease, HDL3, apolipoprotein E, acute phase proteins, atherosclerosis, cardiovascular disease
- MeSH terms
- Amino Acid Sequence, Chromatography, Liquid, Complement Activation, Coronary Artery Disease, Humans, Inflammation, Lipoproteins, HDL, Microscopy, Electron, Scanning, Molecular Sequence Data, Peptide Hydrolases, Mass Spectrometry, Proteomics, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
